ЭФФЕКТИВНОСТЬ КОЖНОГО ТЕСТА С АЛЛЕРГЕНОМ ТУБЕРКУЛЕЗНЫМ РЕКОМБИНАНТНЫМ ПРИ ВЫЯВЛЕНИИ ТУБЕРКУЛЕЗА У ДЕТЕЙ И ПОДРОСТКОВ МОСКВЫ В 2013 Г.
https://doi.org/10.15690/pf.v12i1.1255
Аннотация
Об авторах
Л. В. СлогоцкаяРоссия
доктор медицинских наук, заведующая научно-клиническим отделом ГКУЗ «Московский городской научно-практический центр борьбы с туберкулезом Департамента здравоохранения города Москвы», профессор кафедры фтизиатрии РМАПО
О. Ю. Сенчихина
Россия
Г. В. Никитина
Россия
Е. М. Богородская
Россия
Список литературы
1. Lein A., von Reyn C., Ravn P. et al. Cellular immune responses to ESAT-6 discriminate between patients with pulmonary disease due to Mycobacterium avium complex and those with pulmonary disease due to Mycobacterium tuberculosis. Clin Diagn Lab Immunol. 1999; 6: 606–609.
2. Mahairas G., Sabo P., Hickey M. et al. Molecular analysis of genetic differences between Mycobacterium bovis BCG and virulent M. bovis. J Bacteriol. 1996; 178: 1274–1282.
3. Andersen P., Doherty T., Pai M., Weldingh K. The prognosis of latent tuberculosis: can disease be predicted? Trends Mol Med. 2007; 13 (5): 175–182.
4. Ewer K., Deeks J., Alvarez L. et al. Comparison of T-cell-based assay with tuberculin skin test for diagnosis of Mycobacterium tuberculosis infection in a school tuberculosis outbreak. Lancet. 2003; 361: 1168–1173.
5. Arend S., Thijsen S., Leyten E. et al. Comparison of two interferongamma assays and tuberculin skin test for tracing tuberculosis contacts. Am J Respir Crit Care Med. 2007; 175 (6): 618–627.
6. Menzies D., Pai M., Comstock G. Meta-analysis: new tests for the diagnosis of latent tuberculosis infection: areas of uncertainty and recommendations for research. Ann Intern Med. 2007; 146: 340–354.
7. Mack U., Migliori G., Sester M. et al. LTBI: latent tuberculosis infection or lasting immune responses to Mycobacterium tuberculosis? A TBNET consensus statement. Eur Respir J. 2009; 33: 956–973.
8. Pai M., Zwerling A., Menzies D. Systematic review: T-cell-based assays for the diagnosis of latent tuberculosis infection: an update. Ann Intern Med. 2008; 149 (3): 177–184.
9. Andersen P., Andersen A., Sorensen A., Nagai S. Recall of longlived immunity to Mycobacterium tuberculosis infection in mice. J Immunol. 1995; 154 (7): 3359–72.
10. Vordermeier H., Chambers M., Cockle P. et al. Correlation of ESAT-6-specific gamma interferon production with pathology in cattle following Mycobacterium bovis BCG vaccination against experimental bovine tuberculosis. Infect Immun. 2002; 70: 3026–3032.
11. Dietrich J., Aagaard C., Leah R. et al. Exchanging ESAT6 with ТВ 10.4 in an Ag85B fusion molecule-based tuberculosis subunit vaccine: efficient protection and ESAT6-based sensitive monitoring of vaccine efficacy. J Immunol. 2005; 174: 6332–6339.
12. Bakir M., Millington K., Soysal A. et al. Prognostic value of a T-cell-based, interferon- biomarker in children with tuberculosis contact. Ann Intern Med. 2008; 149: 777–787.
13. Diel R., Loddenkemper R., Meywald-Walter K. et al. Predictive value of a whole blood IFN-gamma assay for the development of active tuberculosis disease after recent infection with Mycobacterium tuberculosis. Am J Respir Crit Care Med. 2008; 177 (10): 1164–1170.
14. Doherty T., Demissie A., Olobo J. et al. Immune responses to the Mycobacterium tuberculosis-specific antigen ESAT-6 signal subclinical infection among contacts of tuberculosis patients. J Clin Microbiol. 2002; 40 (2): 704–706.
15. Lienhardt C., Fielding K., Hane A. et al. Evaluation of the Prognostic Value of IFN- Release Assay and Tuberculin Skin Test in Household Contacts of Infectious Tuberculosis Cases in Senegal. PLoS ONE. 2010; 5 (5): e10508. Doi: 10.1371/journal. pone.0010508.
16. Mazurek G., Weis S., Moonan P. et al. Prospective comparison of the tuberculin skin test and two whole-blood interferon-gamma release assays in persons with suspected tuberculosis. Clin Infect Dis. 2007; 45: 837–845.
17. Diel R., Nienhaus A., Schaberg T. Cost-effectiveness of isoniazid chemoprevention in close contacts. Eur Respir J. 2005; 26: 465–473.
18. Dosanjh D., Hinks T., Innes J. et al. Improved diagnostic evaluation of suspected tuberculosis. Ann Intern Med. 2008; 148: 325–336.
19. Goletti D., Stefania C., Butera O. et al. Accuracy of immunodiagnostic tests for active tuberculosis using single and combined results: a multicenter TBNET Study. PLoS ONE. 2008; 3: e3417.
20. Brandli O., Desgrandchamps D., Gabathuler U. et al. Manual of Tuberculosis. Bern, Swiss Lung League. 2007. URL: www.lung.ch
21. National Institute for Health and Clinical Excellence. Tuberculosis: Clinical Diagnosis and Management of Tuberculosis, and Measures for its Prevention and Control. London, National Institute for Health and Clinical Excellence. 2006. URL: www.nice.org.uk.
22. The National Collaborating Centre for Chronic Conditions. Tuberculosis. Clinical Diagnosis and Management of Tuberculosis, and Measures for its Prevention and Control. London, Royal College of Physicians. 2006.
23. Борисов С. Е., Лукина Г. В., Слогоцкая Л. В., Кочетков Я. А., Гунтупова Л. Д., Куликовская Н. В. Скрининг и мониторинг туберкулезной инфекции у ревматологических больных, получающих генно-инженерные биологические препараты. Туберкулез и болезни легких. 2011; 6: 42–50.
24. Mazurek G., Jereb J., Lobue P. et al. Guidelines for using the Quanti FERON-TB Gold test for detecting Mycobacterium tuberculosis infection, United States. MMWR Recomm Rep. 2005; 54: 49–55.
25. Киселев В. И., Барановский П. М., Пупышев С. А. и др. Новый кожный тест для диагностики туберкулеза на основе рекомбинантного белка ESAT-CFP. Молекулярная медицина. 2008; 4: 4–6.
26. Lalvani A., Millington K. A. T cell-based diagnosis of childhood tuberculosis infection. Curr Opin Infect Dis. 2007; 20: 264–271.
27. Lalvani A. Diagnosing tuberculosis infection in the 21st century: new tools to tackle an old enemy. Chest. 2007; 131: 1898–1906.
28. Mori T., Sakatani M., Yamagishi F. et al. Specific detection of tuberculosis infection: an interferon-c-based assay using new antigens. Am J Respir Crit Care Med. 2004; 170: 59–64.
29. Pai M., Kalantri S., Dheda K. New tools and emerging technologies for the diagnosis of tuberculosis: part I. Latent tuberculosis. Expert Rev Mol Diagn. 2006; 6: 413–422.
30. Richeldi L., Ewer K., Losi M. et al. Early diagnosis of subclinical multidrug-resistant tuberculosis. Ann Intern Med. 2004; 140: 709–713.
31. Слогоцкая Л. В., Сенчихина О. Ю., Богородская Е. М. Чувствительность теста с аллергеном туберкулезным рекомбинантным, содержащим белок ESAT6-CFP10, у впервые выявленных больных туберкулезом детей и подростков в г. Москве. Туберкулез и социально значимые заболевания. 2013; 1: 37–44.
Рецензия
Для цитирования:
Слогоцкая Л.В., Сенчихина О.Ю., Никитина Г.В., Богородская Е.М. ЭФФЕКТИВНОСТЬ КОЖНОГО ТЕСТА С АЛЛЕРГЕНОМ ТУБЕРКУЛЕЗНЫМ РЕКОМБИНАНТНЫМ ПРИ ВЫЯВЛЕНИИ ТУБЕРКУЛЕЗА У ДЕТЕЙ И ПОДРОСТКОВ МОСКВЫ В 2013 Г. Педиатрическая фармакология. 2015;12(1):99-103. https://doi.org/10.15690/pf.v12i1.1255
For citation:
Slogotskaya L.V., Senchikhina O.Y., Nikitina G.V., Bogorodskaya E.M. EFFECTIVENESS OF TUBERCULOUS RECOMBINANT ALLERGEN SKIN TESTS FOR DETECTING TUBERCULOSIS IN CHILDREN AND ADOLESCENTS OF MOSCOW IN 2013. Pediatric pharmacology. 2015;12(1):99-103. (In Russ.) https://doi.org/10.15690/pf.v12i1.1255